|
Domain
|
Median time to improve (mo.)
|
Range (mo.)
|
Durability of improve*
|
Median time to worsening (mo.) (range)
|
Range (mo.)
|
|---|
|
Visual Acuity/Field
|
3.2
|
0.1 - 30.1
|
92.7%
|
25.0
|
0.2 - 98.2
|
|
Diplopia/Ptosis
|
4.6
|
0.6 - 128.7
|
88.2%
|
47.0
|
0.5 - 85.9
|
|
Facial Sensation
|
4.8
|
0.6 - 58.6
|
93.3%
|
17.3
|
2.5 - 102.7
|
|
Facial Weakness
|
16.8
|
1.1 - 42.8
|
100%
|
33.3
|
1.9 - 64.9
|
|
Hearing
|
--
|
2.1 - 2.7
|
--
|
5.1
|
2.5 - 82.8
|
|
Balance
|
2.4
|
2.8 - 2.8
|
100%
|
11.1
|
2.8 - 114.0
|
|
Tinnitus
|
2.8
| |
100%
|
3.5
|
2.4 - 4.6
|
|
Cranial Nerve IX-XII
|
4.9
|
4.2 - 5.6
|
100%
|
24.6
|
6.4 - 31.5
|
|
Other
|
2.4
|
0.5 - 5.6
|
91.7%
|
9.5
|
2.4 - 20.3
|
- * Durability defined as percent of symptoms which after initial improvement remained improved over pre-radiation baseline at the time of last follow-up.
